Metabolism of beclamide, N-benzyl-3-chloropropionamide, in man.
1. Following oral administration of [14C]beclamide to human subjects there was almost complete elimination of radioactivity in the urine within 48 h. 2. Less than 1% of the administered dose was excreted unchanged. 3. The major metabolites were (a) N-(4-hydroxybenzyl)-3-chloropropionamide, (4-hydroxybeclamide; c. 56%), which was eliminated to a small extent in the free form and as a sulphate but mainly as a glucuronide, and (b) hippuric acid (c. 20%). 4. Six minor metabolites were also detected, of which the following were identified: benzoic acid (up to c. 7%), N-(4-hydroxybenzyl-3-chloro-2-hydroxypropionamide, (dihydroxy-beclamide; c. 2%, mostly as a glucuronide) and 4-hydroxybenzoic acid (c. 0.6%, partly as a glucuronide).
D000328:Adult; D000927:Anticonvulsants / Q000378:metabolism* / Q000652:urine; D001565:Benzoates / Q000652:urine; D001596:Benzylamines / Q000378:metabolism / Q000652:urine; D055598:Chemical Phenomena; D002621:Chemistry; D002855:Chromatography, Thin Layer; D006626:Hippurates / Q000652:urine; D006801:Humans; D062385:Hydroxybenzoates / Q000652:urine; D008297:Male; D011422:Propionates / Q000378:metabolism* / Q000652:urine
D000927:Anticonvulsants; D001565:Benzoates; D001596:Benzylamines; D006626:Hippurates; D062385:Hydroxybenzoates; D011422:Propionates